Shedding light on melanocyte pathobiology in vivo

Cancer Research

Volumn 72, Issue 7, 2012, Pages 1591-1595

  Zaidi, M Raza ^a   De Fabo, Edward C ^b   Noonan, Frances P ^b   Merlino, Glenn ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; HLA E ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADJUVANT THERAPY; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CELL ACTIVATION; CUTANEOUS MALIGNANT MELANOMA; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; IN VIVO STUDY; INDUCED MUTATION; MACROPHAGE FUNCTION; MELANOCYTE; MELANOGENESIS; MELANOMA; MELANOMA CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; TUMOR MICROENVIRONMENT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ANIMALS; DNA DAMAGE; HUMANS; INTERFERON-GAMMA; MELANOCYTES; MELANOMA; NEOPLASMS, RADIATION-INDUCED; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84859418552     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-2586     Document Type: Review

References (29)

1. Tran TT, Schulman J, Fisher DE. UV and pigmentation: molecular mechanisms and social controversies. Pigment Cell Melanoma Res 2008;21:509-16.
2. Bennett DC. Ultraviolet wavebands and melanoma initiation. Pigment Cell Melanoma Res 2008;21:520-4.
3. Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, et al. Neonatal sunburn and melanoma in mice. Nature 2001;413:271-2. (Pubitemid 32905840)
4. Klug HL, Tooze JA, Graff-Cherry C, Anver MR, Noonan FP, Fears TR, et al. Sunscreen prevention of melanoma in man and mouse. Pigment Cell Melanoma Res 2010;23:835-7.
5. De Fabo EC, Noonan FP, Fears T, Merlino G. Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res 2004;64: 6372-6. (Pubitemid 39297887)
6. Black HS, deGruijl FR, Forbes PD, Cleaver JE, Ananthaswamy HN, deFabo EC, et al. Photocarcinogenesis: an overview. J Photochem Photobiol B 1997;40:29-47.
7. Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res 2005;571: 91-106. (Pubitemid 40313435)
8. Chen YJ, Chang JG, Shih LS, Chen PH, Endo M, Whang-Peng J, et al. Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. Int J Cancer 1997;71: 350-4. (Pubitemid 27224295)
9. Hocker T, Tsao H. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum Mutat 2007;28:578-88. (Pubitemid 46744288)
10. Wang Y, Digiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, et al. Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A 2009;106:6279-84.
11. Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J, et al. NISC Comparative Sequencing Program. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 2011;43: 442-6.
12. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010; 463:191-6.
13. De Fabo EC, Noonan FP. Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J Exp Med 1983;158:84-98. (Pubitemid 13073514)
14. Zaidi MR, Hornyak TJ, Merlino G. A genetically engineered mouse model with inducible GFP expression in melanocytes. Pigment Cell Melanoma Res 2011;24:393-4.
15. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, et al. Interferon-g links ultraviolet radiation to melanomagenesis in mice. Nature 2011;469:548-53.
16. Wolnicka-Glubisz A, Damsker J, Constant S, Corn S, De Fabo E, Noonan F. Deficient inflammatory response to UV radiation in neonatal mice. J Leukoc Biol 2007;81:1352-61. (Pubitemid 46830600)
17. Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006;6:836-48. (Pubitemid 44631652)
18. Zaidi MR, Merlino G. The two faces of interferon-γ in cancer. Clin Cancer Res 2011;17:6118-24.
19. Wischhusen J, Waschbisch A, Wiendl H. Immune-refractory cancers and their little helpers-an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E? Semin Cancer Biol 2007; 17:459-68. (Pubitemid 350052592)
20. Rebmann V, Wagner S, Grosse-Wilde H. HLA-G expression in malignant melanoma. Semin Cancer Biol 2007;17:422-9. (Pubitemid 350052587)
21. Derré L, Corvaisier M, Charreau B, Moreau A, Godefroy E, Moreau- Aubry A, et al. Expression and release of HLA-E by melanomacells and melanocytes: potential impact on the response of cytotoxic effector cells. J Immunol 2006;177:3100-7. (Pubitemid 44277827)
22. Chen Z, Koralov SB, Kelsoe G. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med 2000;192:1339-52.
23. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008;322:271-5.
24. Schwarz A, Beissert S, Grosse-Heitmeyer K, Gunzer M, Bluestone JA, Grabbe S, et al. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation- induced tolerance. J Immunol 2000;165: 1824-31. (Pubitemid 30643132)
25. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-23.
26. Meyskens FL Jr, Kopecky KJ, Taylor CW, Noyes RD, Tuthill RJ, Hersh EM, et al. Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study. J Natl Cancer Inst 1995;87:1710-3.
27. Oble DA, Loewe R, Yu P, Mihm MC Jr. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun 2009;9:3.
28. Porter GA, Abdalla J, Lu M, Smith S, Montgomery D, Grimm E, et al. Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes. Ann Surg Oncol 2001;8:116-22. (Pubitemid 32199407)
29. Cho HI, Lee YR, Celis E. Interferon γ limits the effectiveness of melanoma peptide vaccines. Blood 2011;117:135-44.